EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression and prognostic significance of the PD ‐1/ PD‐L1 pathway in AIDS ‐related non‐Hodgkin lymphoma

Han Zhao iD, Shaohang Cai, Yanhua Xiao, Muye Xia, Hongjie Chen, Zhiman Xie, Xiaoping Tang, Haolan He, Jie Peng, Juanjuan Chen iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.7195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Han Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, Epstein-Barr Virus Infections, Lymphoma, Non-Hodgkin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GuangDong Basic and Applied Basic Research Foundation, Municipal and University (Hospital) joint funding project of Guangzhou Municipal Science and Technology Bureau, Clinical Research Program of Nanfang Hospital, Southern Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Immune tolerance and evasion play a critical role in virus‐driven malignancies. However, the phenotype and clinical significance of programmed cell death 1 (PD‐1) and its ligands, PD‐L1 and PD‐L2, in aggressive acquired immunodeficiency syndrome (AIDS)‐related non‐Hodgkin lymphoma (AR‐NHL) remain poorly understood, particularly in the Epstein–Barr virus (EBV)‐positive subset.

Methods

We used in situ hybridization with EBV‐encoded RNA (EBER) to assess the EBV status. We performed immunohistochemistry and flow cytometry analysis to evaluate components of the PD‐1/PD‐L1/L2 pathway in a multi‐institutional cohort of 58 patients with AR‐NHL and compared EBV‐positive and EBV‐negative cases.

Results

The prevalence of EBV + in AR‐NHL was 56.9% and was associated with a marked increase in the expression of PD‐1/PD‐L1/PD‐L2 in malignant cells. Patients with AR‐NHLs who tested positive for both EBER and PD‐1 exhibited lower survival rates compared to those negative for these markers (47.4% vs. 93.8%, p = 0.004). Similarly, patients positive for both EBER and PD‐L1 also demonstrated poorer survival (56.5% vs. 93.8%, p = 0.043). Importantly, PD‐1 tissue‐expression demonstrated independent prognostic significance for overall survival in multivariate analysis and was correlated to elevated levels of LDH ( r = 0.313, p = 0.031), increased PD‐1 + Tregs ( p = 0.006), and robust expression of EBER ( r = 0.541, p < 0.001) and PD‐L1 ( r = 0.354, p = 0.014) expression.

Conclusions

These data emphasize the importance of PD‐1‐mediated immune evasion in the complex landscape of immune oncology in AR‐NHL co‐infected with EBV, and contribute to the diagnostic classification and possible definition of immunotherapeutic strategies for this unique subgroup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acquired Immunodeficiency SyndromeEpstein-Barr Virus InfectionsLymphoma, Non-HodgkinHumansProgrammed Cell Death 1 ReceptorB7-H1 AntigenPrognosisHerpesvirus 4, Human

Stichwörter der Autor:innen

Epstein–Barr virusacquired immunodeficiency syndromenon‐Hodgkin lymphomaprogrammed cell death protein 1regulatory T cells

Substanzen

Programmed Cell Death 1 ReceptorB7-H1 Antigen

Autor:innen und Institutionen

  • Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Infectious Diseases Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Pathology department, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Guangxi AIDS Clinical Treatment Center, the Fourth People's Hospital of Nanning, Nanning, China.

ORCID-Profile: Han Zhao, Juanjuan Chen

Förderung

  • GuangDong Basic and Applied Basic Research Foundation
  • Municipal and University (Hospital) joint funding project of Guangzhou Municipal Science and Technology Bureau
  • Clinical Research Program of Nanfang Hospital, Southern Medical University
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Zhao, H., Cai, S., Xiao, Y., Xia, M., Chen, H., Xie, Z., Tang, X., He, H., Peng, J., & Chen, J. (2024). Expression and prognostic significance of the PD ‐1/ PD‐L1 pathway in AIDS ‐related non‐Hodgkin lymphoma. Cancer Medicine. https://doi.org/10.1002/cam4.7195

Vancouver

Zhao H, Cai S, Xiao Y, Xia M, Chen H, Xie Z, et al. Expression and prognostic significance of the PD ‐1/ PD‐L1 pathway in AIDS ‐related non‐Hodgkin lymphoma. Cancer Medicine. 2024. doi:10.1002/cam4.7195

BibTeX
@article{Zhao2024,
  author = {Zhao, Han and Cai, Shaohang and Xiao, Yanhua and Xia, Muye and Chen, Hongjie and Xie, Zhiman and Tang, Xiaoping and He, Haolan and Peng, Jie and Chen, Juanjuan},
  title = {Expression and prognostic significance of the PD ‐1/ PD‐L1 pathway in AIDS ‐related non‐Hodgkin lymphoma},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7195}
}
Kostenlos starten →